B7-H3 (CD276), a member of the B7 immunoglobulin superfamily, is a type I transmembrane protein that is notably overexpressed in various solid tumors, including bladder cancer, prostate cancer, and melanoma, while exhibiting limited expression in normal tissues. This evidence concerns the gene CD276 and prostate carcinoma.